SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001274644-16-000136
Filing Date
2016-10-17
Accepted
2016-10-17 08:28:15
Documents
1
Period of Report
2016-10-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_147670728284215.html 4  
1 FORM 4 wf-form4_147670728284215.xml 4 3083
  Complete submission text file 0001274644-16-000136.txt   4581
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OCERA THERAPEUTICS 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301
Business Address
Bukofzer Stan (Reporting) CIK: 0001663041 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 161938060